The American College of Neuropsychopharmacology, known as the ACNP, has honored Lieber Institute for Brain Development Lead Investigator Keri Martinowich, Ph.D., with the 2023 Daniel H. Efron Research Award.
The annual award honors an individual for their outstanding basic research contributions to the field of neuropsychopharmacology. The ACNP will present the award in person at its 62nd annual conference, Dec. 3 – 6.
Dr. Martinowich joined the Lieber Institute in 2012 and now oversees a robust lab that uses cutting-edge spatial transcriptomics techniques to better understand the brain mechanisms behind human behavior.
Watch a video of her acceptance speech.
“I have been attending the ACNP meeting regularly since 2007,” said Dr. Martinowich. “It is my favorite meeting of the year. The meeting and the connections that I have developed through attending have played an important role in my career and in our lab’s research.”
“I’d like to thank all of the members of our research group, both past and present for all of their hard work, dedication and making the lab what it is today,” she added.
Lieber Institute Director & CEO Daniel Weinberger, M.D., nominated Dr. Martinowich for the Efron Award. Watch a video of his remarks.
“It was my honor to nominate Dr. Martinowich for this well-deserved recognition,” says Dr. Weinberger. “Her productivity and leadership in research have led to pioneering discoveries in the molecular regulation of the circuits that govern behavior, as well as the understanding of cell type and spatially resolved patterns of gene expression in the brain.”
Dr. Weinberger worked with Dr. Martinowich at the NIH and recruited her to the Lieber Institute soon after its founding.
“Her bold and creative style is critical to developing novel molecular therapeutics for neuropsychiatric, neurodevelopmental and neurodegenerative disorders,” he added. “Dr. Martinowich personifies the meaning of the Daniel H. Efron Award.”